Biopharma Plasma company information, Employees & Contact Information

The top biopharma conferences in 2026 BioPharma Dive

Biopharma layoffs rise as drugmakers tighten belts and reorganize Pharma Voice

The Top 12 Companies Hiring in Biopharma Now BioSpace

Top 10 U.S. Biopharma Clusters 2025 Genetic Engineering and Biotechnology News

Biopharma layoffs for first half of the year jump 32% YOY Fierce Biotech

Funding drought: how can biotech and biopharma keep trials running? Clinical Trials Arena

Simplification for success: Rewiring the biopharma operating model McKinsey & Company

Biopharma M&A: Outlook for 2025 IQVIA

Grove Biopharma Closes $30 Million Series A Financing to Advance Bionic Biologics , a New Therapeutic Modality Business Wire

The top 10 biopharma M&A deals of 2024 Fierce Pharma

Top 20 Pharma and BioPharma Companies Archives Contract Pharma

China biotechs ‘reshaping’ US biopharma as outlicensing deals rise 11%: Jefferies report Fierce Biotech

Gen AI: A game changer for biopharma operations McKinsey & Company

Seven Biopharma Trends to Watch in 2025 Genetic Engineering and Biotechnology News

A 'wake up call' for US leadership: Mass biopharma industry group gives gloomy forecast WGBH

Trends Shaping Biopharma in 2025 Deloitte

Reigniting Biopharma’s Research Engine Boston Consulting Group

Q1 biopharma layoff trends, plus expectations for Q2 Fierce Biotech

Closing the women’s health gap: Biopharma’s untapped opportunity McKinsey & Company

How a global biopharma is adopting an end-to-end AI transformation McKinsey & Company

2024’s Top Employers: Who did Science readers select as best in biopharma? Science | AAAS

Accelerating clinical trials to improve biopharma R&D productivity McKinsey & Company

Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return Reuters

Quantum BioPharma Makes Strategic Investment in GameStop Corp. Yahoo Finance

Deep Dive: Women in Biopharma BioSpace

Trade war: how new U.S. tariffs will impact the biopharma industry Labiotech.eu

Sanofi to buy US biopharma group Blueprint for up to $9.5 billion Reuters

Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum GlobeNewswire

Biopharma M&A outlook for 2024 IQVIA

U.S. investors, Big Pharma race to find new medicines in China CNBC

Five ways biopharma companies can navigate the deal landscape McKinsey & Company

Year of biotech layoffs leaves industry looking for spark BioPharma Dive

Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies PR Newswire

The 5 Most Powerful Women in Biopharma BioSpace

Biopharma company to create 401 jobs in Wilson WRAL.com

Digitalized supply chains are essential to biopharma's future Deloitte

BioSpace Announces 2025 Best Places to Work in Biopharma BioSpace

2024 drug approvals: Small companies loom large with several key FDA nods Fierce Pharma

Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial GlobeNewswire

Biopharma’s Path to Value with Generative AI Boston Consulting Group

Biopharma Bankruptcies Still At Peak, With Little Relief in Sight BioSpace

Reimagining the future of biopharma manufacturing McKinsey & Company

Top 5 highest paid biopharma R&D executives in 2023 Fierce Biotech

Top 10 U.S. Biopharma Clusters 2024 Genetic Engineering and Biotechnology News

Top 10 smartest deals in biopharma Fierce Biotech

AI in biopharma research: A time to focus and scale McKinsey & Company

The Helix report: Is biopharma wired for future success? McKinsey & Company

Integrated evidence generation: A paradigm shift in biopharma McKinsey & Company

The biopharma “brain drain”: Finding talent to fuel innovation Fierce Pharma

Vision 2028: How China could impact the global biopharma industry McKinsey & Company

Biopharma digital transformation: Gain an edge with leapfrog digital innovation Deloitte

Biopharma Boston Consulting Group

Helicore Biopharma Emerges from Stealth to Continue GlobeNewswire

The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial The Guardian

Biopharma VC activity slipped last year—but 'buoyant' molecular glue market holds hope: PitchBook Fierce Biotech

The dawn of China biopharma innovation McKinsey & Company

Gwendolyn Wu BioPharma Dive

Transforming biopharma R&D at scale McKinsey & Company

Opinion: A Cautiously Sunny Outlook for Biopharma in 2025 BioSpace

Top 10 U.S. Biopharma Clusters Genetic Engineering and Biotechnology News

The top 10 biopharma M&A deals in 2021 Fierce Pharma

The top 10 biopharma M&A deals of 2022 Fierce Pharma

Biotech’s M&A outlook is uncertain. Track the deals that are happening here. BioPharma Dive

Most influential people in biopharma—the entrepreneurs Fierce Pharma

The rise of artificial intelligence across biopharma Deloitte

Will Quantum Computing Transform Biopharma R&D? Boston Consulting Group

Top 10 U.S. Biopharma Clusters 2021 Genetic Engineering and Biotechnology News

The top 15 biopharma licensing deals of 2020 Fierce Biotech

The top 10 best-paying places to work in biopharma Fierce Pharma

What Does—and Does Not—Drive Biopharma Cost Performance Boston Consulting Group

Top 10 U.S. Biopharma Clusters 2018 Genetic Engineering and Biotechnology News

Why Singapore is a top choice for biopharma firms seeking global expansion Singapore Economic Development Board (EDB)

iX Biopharma shares jump 35% on potential US, Australia listing plans The Business Times